According to the Voice of China "National News stake online sports bettingstake sports betting appNetwork" report，The 3rd China Biological Industry Conference opened today，Sino -US government、multinational and local pharmaceutical companies discuss the management and development of the biopharmaceutical market。CFDA Represents，It will implement electronic supervision of the minimum packaging of all listed drugs by 2015。
 
Current，Biotechnology and drugs have been widely used in treating cancer、AIDS and other major diseases and cystic fiber degeneration and other rare diseases。Although China takes the lead in developing biological preparations such as H1N1 influenza vaccine and penta hepatitis vaccine，But in the pharmaceutical market of $ 70 billion annually in my country，The proportion of biological preparations and biological drugs is only 10%。U.S. ambassador to China Luo Jiahui believes，Excessive approval process，To a My stake betting appStake Sports Bettingcertain extent, it affects the rapid development of the Chinese biopharmaceutical market。
 
Luo Jiahui: According to an industrial report，A new medicine for approval in China，It is 5 years slower than the international market average。The clinical trial application of drugs will take an average of 19-22 months in China to get approved，Far slower than South Korea，Even Hong Kong, China。These factors will seriously affect the scope of transnational companies that include China in their own new drug test。
 
Chinese drug supervision & ldquo; strict & rdquo;，Bian Zhenjia, a member of the Party Group of the State Food and Drug Administration, said，This situation will continue。
 
Border Zhenjia: Strive to fully implement electronic supervision of all listed drugs in 2015，To achieve the minimum packaging of all medicines can be tracked，Realize the quality stake sports betting appstake online sports bettingtraceability of the entire process of medicine。Promote the new version of the drug GMP (drug production quality management specification) among all drug manufacturers (specifications)，Forced blood products before the end of 2013、Vaccine、Sterile drugs meet the new version of GMP requirements，All other drug categories production of other drugs before the end of 2015 meets the requirements of the new version of the drug GMP。